CORDIS
EU research results

CORDIS

English EN

Outcome and impact of specific treatment in european research on melanoma (OISTER)

Project information

Grant agreement ID: QLG1-CT-2002-00668

  • Start date

    1 October 2002

  • End date

    30 September 2005

Funded under:

FP5-LIFE QUALITY

  • Overall budget:

    € 1 948 600

  • EU contribution

    € 1 636 300

Coordinated by:

GERMAN CANCER RESEARCH CENTER

Germany

Objective

Human melanoma is highly resistant to any kind of treatment, but the underlying reasons are largely unknown. OISTER aims to collect tissue samples and cell lines together with relevant clinical data in order to correlate the tumour characteristics with the clinical information, especially response to treatment with the final objective of using this knowledge to enhance treatment success in this refractory disease. This will be achieved by analyses at the genetic and proteomic level and correlation of the results with the clinical data using artificial neural network bio informatics programs. Integration of pre-existing md newly-built data bases with ESTDAB, an EU-funded infrastructure project, aimed to establish the largest collection of fully-characterised melanoma cell lines in Europe and the world, will provide tools to identify new biomarkers and tumour-associated antigens associated with prognosis and responsiveness to treatment.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

GERMAN CANCER RESEARCH CENTER

Address

Universitaetsklinikum Mannheim - Theodor Kutzer Uf
68135 Mannheim

Germany

Participants (6)

DANISH CANCER SOCIETY

Denmark

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

France

SAINT SAVAS CANCER HOSPITAL

Greece

THE NOTTINGHAM TRENT UNIVERSITY

United Kingdom

THE UNIVERSITY OF TUEBINGEN

Germany

UNIVERSIDAD DE CORDOBA

Spain

Project information

Grant agreement ID: QLG1-CT-2002-00668

  • Start date

    1 October 2002

  • End date

    30 September 2005

Funded under:

FP5-LIFE QUALITY

  • Overall budget:

    € 1 948 600

  • EU contribution

    € 1 636 300

Coordinated by:

GERMAN CANCER RESEARCH CENTER

Germany